Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood
- PMID: 27074389
- DOI: 10.1056/NEJMoa1503840
Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood
Abstract
Background: In light of the worldwide increase in childhood obesity, we examined the association between body-mass index (BMI) in late adolescence and death from cardiovascular causes in adulthood.
Methods: We grouped data on BMI, as measured from 1967 through 2010 in 2.3 million Israeli adolescents (mean age, 17.3±0.4 years), according to age- and sex-specific percentiles from the U.S. Centers for Disease Control and Prevention. Primary outcomes were the number of deaths attributed to coronary heart disease, stroke, sudden death from an unknown cause, or a combination of all three categories (total cardiovascular causes) by mid-2011. Cox proportional-hazards models were used.
Results: During 42,297,007 person-years of follow-up, 2918 of 32,127 deaths (9.1%) were from cardiovascular causes, including 1497 from coronary heart disease, 528 from stroke, and 893 from sudden death. On multivariable analysis, there was a graded increase in the risk of death from cardiovascular causes and all causes that started among participants in the group that was in the 50th to 74th percentiles of BMI (i.e., within the accepted normal range). Hazard ratios in the obese group (≥95th percentile for BMI), as compared with the reference group in the 5th to 24th percentiles, were 4.9 (95% confidence interval [CI], 3.9 to 6.1) for death from coronary heart disease, 2.6 (95% CI, 1.7 to 4.1) for death from stroke, 2.1 (95% CI, 1.5 to 2.9) for sudden death, and 3.5 (95% CI, 2.9 to 4.1) for death from total cardiovascular causes, after adjustment for sex, age, birth year, sociodemographic characteristics, and height. Hazard ratios for death from cardiovascular causes in the same percentile groups increased from 2.0 (95% CI, 1.1 to 3.9) during follow-up for 0 to 10 years to 4.1 (95% CI, 3.1 to 5.4) during follow-up for 30 to 40 years; during both periods, hazard ratios were consistently high for death from coronary heart disease. Findings persisted in extensive sensitivity analyses.
Conclusions: A BMI in the 50th to 74th percentiles, within the accepted normal range, during adolescence was associated with increased cardiovascular and all-cause mortality during 40 years of follow-up. Overweight and obesity were strongly associated with increased cardiovascular mortality in adulthood. (Funded by the Environment and Health Fund.).
Comment in
-
Teenagers at upper end of normal body weight have higher mortality in adult life, study shows.BMJ. 2016 Apr 17;353:i2192. doi: 10.1136/bmj.i2192. BMJ. 2016. PMID: 27091881 No abstract available.
-
Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.N Engl J Med. 2016 Sep 29;375(13):1300-1. doi: 10.1056/NEJMc1609415. N Engl J Med. 2016. PMID: 27682045 No abstract available.
-
Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.N Engl J Med. 2016 Sep 29;375(13):1299. doi: 10.1056/NEJMc1609415. N Engl J Med. 2016. PMID: 27682046 No abstract available.
-
Body-Mass Index in Adolescence and Cardiovascular Death in Adulthood.N Engl J Med. 2016 Sep 29;375(13):1300. doi: 10.1056/NEJMc1609415. N Engl J Med. 2016. PMID: 27682047 No abstract available.
-
Adolescent BMI greater than 50% is associated with adult cardiovascular-death risk.J Pediatr. 2016 Nov;178:304-305. doi: 10.1016/j.jpeds.2016.08.070. J Pediatr. 2016. PMID: 27788841 No abstract available.
-
Body mass index in adolescence may influence the risk of cardiovascular disease later in life.Evid Based Nurs. 2017 Apr;20(2):50. doi: 10.1136/eb-2016-102506. Epub 2017 Jan 20. Evid Based Nurs. 2017. PMID: 28108501 No abstract available.
Similar articles
-
BMI at Age 17 Years and Diabetes Mortality in Midlife: A Nationwide Cohort of 2.3 Million Adolescents.Diabetes Care. 2016 Nov;39(11):1996-2003. doi: 10.2337/dc16-1203. Epub 2016 Oct 12. Diabetes Care. 2016. PMID: 27733421
-
Adolescent Body Mass Index and Cardiovascular Disease-Specific Mortality by Midlife.J Clin Endocrinol Metab. 2017 Aug 1;102(8):3011-3020. doi: 10.1210/jc.2017-00329. J Clin Endocrinol Metab. 2017. PMID: 28666367
-
Hypertension in late adolescence and cardiovascular mortality in midlife: a cohort study of 2.3 million 16- to 19-year-old examinees.Pediatr Nephrol. 2016 Mar;31(3):485-92. doi: 10.1007/s00467-015-3240-1. Epub 2015 Oct 27. Pediatr Nephrol. 2016. PMID: 26508439
-
Screening and Interventions for Childhood Overweight [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. PMID: 20722132 Free Books & Documents. Review.
-
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-1. PMID: 27559550 Free Books & Documents. Review.
Cited by
-
Improvement in Symptoms of Depression and Anxiety and Cardiometabolic Risk Factors in Children and Adolescents with Overweight and Obesity Following the Implementation of a Multidisciplinary Personalized Lifestyle Intervention Program.Nutrients. 2024 Oct 30;16(21):3710. doi: 10.3390/nu16213710. Nutrients. 2024. PMID: 39519542 Free PMC article.
-
Associations of Adolescence Exposure to Industrial Air Pollution with Cancer in Young Adults.Environ Health (Wash). 2023 Jun 21;1(1):53-62. doi: 10.1021/envhealth.3c00030. eCollection 2023 Jul 21. Environ Health (Wash). 2023. PMID: 39474627 Free PMC article.
-
Changes in Prevalence and Phenotype of Hypertension in Children Suspected of Hypertension Using the 2022 American Heart Association Guidelines.Glob Pediatr Health. 2024 Oct 16;11:2333794X241287304. doi: 10.1177/2333794X241287304. eCollection 2024. Glob Pediatr Health. 2024. PMID: 39429535 Free PMC article.
-
The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.Sci Rep. 2024 Oct 18;14(1):24433. doi: 10.1038/s41598-024-75965-2. Sci Rep. 2024. PMID: 39424950 Free PMC article.
-
Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists.JAMA Pediatr. 2024 Oct 14:e243812. doi: 10.1001/jamapediatrics.2024.3812. Online ahead of print. JAMA Pediatr. 2024. PMID: 39401009
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources